Toshiba’s high-performance Aplio scanner just got an upgrade. The Aplio xV debuting at the RSNA meeting features standard and optional software designed for radiology and cardiology.
Toshiba's high-performance Aplio scanner just got an upgrade. The Aplio xV debuting at the RSNA meeting features standard and optional software designed for radiology and cardiology.
Several features, announced several months ago as part of the company's Version 5.5 software release, have been repackaged under the new label. These include automated one-touch Quick Scan image optimization and Differential Harmonic Imaging. Standard bearers on the Aplio platform include expanded field-of-view trapezoid imaging and real-time ApliPure spatial and frequency compounding.
The company is showcasing Differential Harmonic Imaging, which creates an additional frequency to improve the resolution and clarity of visualization of deep structures, according to Gordon Parhar, director of ultrasound imaging for Toshiba American Medical Systems. DHI was developed in Toshiba's laboratory to overcome the challenges of imaging heavier people with a single ultrasound scan.
"If radiologists are not sure of what they are seeing on an ultrasound, they have to send patients off to secondary or other tests, such as a CT or MRI. With Differential Harmonic Imaging, radiologists can get extra confidence in reading ultrasound scans, and they don't have to do those tests," Parhar said.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.